Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 8 Gastrointestinal 2 Gynecologic 1 Genitourinary 1 Breast 1

Conditions

Prostatic Neoplasms 3 Urinary Incontinence 2 Urologic Neoplasms 1 Testicular Neoplasms 1 Motor Activity 1 Lung Neoplasms 1 Castration-resistant Prostate Cancer 1

Interventions

pembrolizumab 26 Magnetic Resonance Spectroscopy 14 Nivolumab 13 Docetaxel 13 Specimen Handling 11 Radiotherapy 9 Paclitaxel 9 Radiosurgery 8 Early Intervention, Educational 8 Cyclophosphamide 8 Gemcitabine 7 atezolizumab 6 Taxes 6 Surveys and Questionnaires 6 Standard of Care 6 Psychiatric Rehabilitation 6 Ipilimumab 6 Carboplatin 6 sargramostim 5 Pemetrexed 5 Methods 5 motexafin gadolinium 4 fludarabine 4 X-Rays 4 Interviews as Topic 4 Immunoglobulin G 4 Fluorouracil 4 Educational Status 4 Cisplatin 4 Biopsy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Neoplasms × Control Groups × Genitourinary × Clear all

NCT05319145 2022-04-13

PROFIT

Hospital Universitari Vall d'Hebron Research Institute

Phase NA Unknown

GenitourinaryThoracic

Lung Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡